References
- National Research Council. Genetic screening: programs, principles and research. National Academy of Sciences, Washington, DC 1975
- US Congress Office of Technology Assessment. Genetic monitoring and screening in the workplace. U.S. Government Printing Office, Washington, DC 1990
- Ethics and human genetics. A cross-cultural perspective, D C. Wertz, J C. Fletcher. Springer-Verlag, Berlin 1989
- Holtzman N A. Proceed with caution. Predicting genetic risks in the recombinant DNA era. Johns Hopkins University Press, Baltimore 1989
- Modell B, Kuliev A M., Wagner M. Community genetics services in Europe. WHO Regional Office for Europe, Copenhagen 1992, WHO Regional Publications, European Series No 38
- Fletcher J C., Berg K, Tranoy K E. Ethical aspects of medical genetics. A proposal for guidelines in genetic counselling, prenatal diagnosis and screening. Clin Genet 1985; 27: 199–205
- Report of the Royal College of Physicians. Prenatal diagnosis and genetic screening; community and service implications. Royal College of Physicians of London. 1989
- Kaback M M., Zeigler R S., Reynolds L W., Sonneborn M. Approaches to the control and prevention of Tay Sachs disease. Prog Med Genet 1974; 10: 103–34
- Clow C L., Scriver C R. Knowledge about and genetic attitudes towards genetic screening among high-school students: the Tay Sachs experience. Pediatrics 1977; 59: 86–91
- Zeesman S, Clow C L., Cartier L, Scriver C R. A private view of heterozygosity: eight-year follow-up study on carriers of the Tay Sachs gene detected by high-school screening in Montreal. Am J Med Gen 1984; 18: 769–78
- Modell B, Ward R HT, Fairweather D VI. Effect of introducing antenatal diagnosis on the reproductive behaviour of families at risk for thalassaemia major. Br Med J 1980; 2: 737
- Old J M., Ward R HT, Petrou M, Karagozlu F, Modell B, Weatherall D J. First-trimester fetal diagnosis for the haemoglobinopathies: three cases. Lancet 1982; ii: 1413–6
- WHO. The haemoglobinopathies in Europe. WHO Regional Office for Europe, Copenhagen 1987, WHO Regional Office for Europe, unpublished document IPC/ MCH 110. (May be obtained free of charge from: Maternal and Child Health Division
- Anionwu E N., Patel N, Kanji G, Renges H, Brosovic M. Counselling for prenatal diagnosis of sickle-cell disease and B-thalassaemia major. A four year experience. J Med Genet 1987; 25: 769
- Petrou M, Brugiatelli M, Ward R HT, Modell B. Factors affecting the uptake of prenatal diagnosis for sickle cell disease. J Med Genet 1992, (in press)
- WHO. Update of the progress of haemoglobinopathies control. WHO, Geneva 1985, Unpublished Report HMG/WG/85.8. The Hereditary Diseases Programme
- Moisley C, Modell B, McKeigue P, Petrou M, Varnavides L, Old J. Use of a patient register for evaluating delivery of screening and genetic counselling for thalassaemia in the UK. 1992, (in press)
- Angastiniotis M A., Kyriakidou S, Hadjiminas M. How thalassaemia was controlled in Cyprus. World Health Forum 1986; 7: 291–7
- Modell M, Modell B. Genetic screening for ethnic minorities. Br Med J 1990; 300: 1702–4
- Crawfurd D, Dodge A, Kerzin-Storrar L, Harris R. Uptake of presymptomatic predictive testing for Huntington's disease. Lancet 1989; ii: 603–5
- Morris M J., Tyler A, Lazarou L, Meredith L, Harper P S. Problems in genetic prediction for Huntington's disease. Lancet 1989; ii: 601–3
- Zerres K, Stephan M. Attitudes to early diagnosis of polycystic kidney disease. Lancet 1986; ii: 1395
- Modell B. Screening as public policy. Prenatal diagnosis and screening, D Brock, C Rodeck, M A. Ferguson-Smith. Churchill Livingstone. 1992, (in press)